Stay updated with breaking news from Alexa Buffa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company announces participation in BTIG Virtual Biotechnology Conference NEW YORK, July 28, 2023 -- MiNK Therapeutics , a clinical-stage biopharmaceutical company specializing in the discovery,...
NEW YORK, June 05, 2023 -- MiNK Therapeutics , a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant... | June 5, 2023
75% survival in patients with severe respiratory distress treated with agenT-797agenT-797 improved lung function, significantly reduced inflammation and secondary infectionsMiNK to advance agenT-797... | May 22, 2023
Allogeneic iNKTs, agenT-797, administered alone or in combination with anti-PD-1 therapy, shows activity in patients with refractory solid tumor cancers.In a patient with metastatic gastric cancer who... | April 18, 2023